Journal of the American College of Radiology
Volume 6, Issue 12 , Pages 876-883 , December 2009

Utilization of Advanced Imaging Technologies for Target Delineation in Radiation Oncology

References 

  1. Amendola BE, McClatchey K, Amendola MA. Pineal region tumors: analysis of treatment results. Int J Radiat Oncol Biol Phys. 1984;10:991–997
  2. Seo Y, Fukuoka S, Takanashi M, Sasaki T, Suematsu K, Nakamura J. Gamma Knife surgery for Cushing's disease. Surg Neurol. 1995;43:170–176
  3. Bucci MK, Bevan A, Roach M. Advances in radiation therapy: conventional to 3D, to IMRT, to 4D, and beyond. CA Cancer J Clin. 2005;55:117–134
  4. Michalski JM, Purdy JA. Innovations in three-dimensional treatment planning and quality assurance. Tumori. 1998;84:127–139
  5. Purdy JA. Advances in three-dimensional treatment planning and conformal dose delivery. Semin Oncol. 1997;24:655–671
  6. Khoo VS, Joon DL. New developments in MRI for target volume delineation in radiotherapy. Br J Radiol. 2006;79:S2–S15
  7. Khoo VS, Dearnaley DP, Finnigan DJ, Padhani A, Tanner SF, Leach MO. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning. Radiother Oncol. 1997;42:1–15
  8. Emami B, Sethi A, Petruzzelli GJ. Influence of MRI on target volume delineation and IMRT planning in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:481–488
  9. Aoyama H, Shirato H, Nishioka T, et al. Magnetic resonance imaging system for three-dimensional conformal radiotherapy and its impact on gross tumor volume delineation of central nervous system tumors. Int J Radiat Oncol Biol Phys. 2001;50:821–827
  10. Buyyounouski MK, Horwitz EM, Price RA, Hanlon AL, Uzzo RG, Pollack A. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2004;58:743–749
  11. Chang J, Thakur SB, Huang W, Narayana A. Magnetic resonance spectroscopy imaging (MRSI) and brain functional magnetic resonance imaging (fMRI) for radiotherapy treatment planning of glioma. Technol Cancer Res Treat. 2008;7:349–362
  12. Grosu AL, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol. 2005;181:483–499
  13. Grosu AL, Weber WA, Astner ST, et al. 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy. Int J Radiat Oncol Biol Phys. 2006;66:339–344
  14. Nestle U, Weber W, Hentschel M, Grosu AL. Biological imaging in radiation therapy: role of positron emission tomography. Phys Med Biol. 2009;54:R1–R25
  15. Schoder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004;34:274–292
  16. Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007;67:709–719
  17. Ahn PH, Garg MK. Positron emission tomography/computed tomography for target delineation in head and neck cancers. Semin Nucl Med. 2008;38:141–148
  18. Guha C, Alfieri A, Blaufox MD, Kalnicki S. Tumor biology-guided radiotherapy treatment planning: gross tumor volume versus functional tumor volume. Semin Nucl Med. 2008;38:105–113
  19. Heron DE, Smith RP, Andrade RS. Advances in image-guided radiation therapy—the role of PET-CT. Med Dosim. 2006;31:3–11
  20. Schillaci O, Filippi L, Manni C, Santoni R. Single-photon emission computed tomography/computed tomography in brain tumors. Semin Nucl Med. 2007;37:34–47
  21. Schillaci O. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma. Semin Nucl Med. 2006;36:275–285
  22. Golder W. Magnetic resonance spectroscopy in clinical oncology. Onkologie. 2004;27:304–309
  23. Kurhanewicz J, Vigneron DB. Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin North Am. 2008;16:697–710
  24. Payne GS, Leach MO. Applications of magnetic resonance spectroscopy in radiotherapy treatment planning. Br J Radiol. 2006;79:S16–S26
  25. Pirzkall A, Li X, Oh J, et al. 3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI. Int J Radiat Oncol Biol Phys. 2004;59:126–137
  26. Pirzkall A, Nelson SJ, McKnight TR, et al. Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy. Int J Radiat Oncol Biol Phys. 2002;53:1254–1264
  27. Roach M, Kurhanewicz J, Carroll P. Spectroscopy in prostate cancer: hope or hype?. Oncology (Williston Park). 2001;15:1399–1410
  28. van Lin EN, Futterer JJ, Heijmink SW, et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys. 2006;65:291–303
  29. Rasey JS, Koh WJ, Evans ML, et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys. 1996;36:417–428
  30. Grosu AL, Molls M, Zimmermann FB, et al. High-precision radiation therapy with integrated biological imaging and tumor monitoring: evolution of the Munich concept and future research options. Strahlenther Onkol. 2006;182:361–368
  31. Slotman BJ, Lagerwaard FJ, Senan S. 4D imaging for target definition in stereotactic radiotherapy for lung cancer. Acta Oncol. 2006;45:966–972
  32. Li G, Citrin D, Camphausen K, et al. Advances in 4D medical imaging and 4D radiation therapy. Technol Cancer Res Treat. 2008;7:67–81
  33. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65–70
  34. Glantz SA. Primer of biostatistics. In: 6th ed.. New York: McGraw-Hill; 2005;p. 103–104

 This study was supported by T32 grant RR023254 from the National Institutes of Health (Bethesda, Md).

PII: S1546-1440(09)00397-4

doi: 10.1016/j.jacr.2009.08.006

Journal of the American College of Radiology
Volume 6, Issue 12 , Pages 876-883 , December 2009